ClariVest Asset Management’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $4.08K | Hold |
53
| – | – | ﹤0.01% | 461 |
|
2024
Q2 | $4.08K | Sell |
53
-214
| -80% | -$16.5K | ﹤0.01% | 461 |
|
2024
Q1 | $18.3K | Buy |
267
+37
| +16% | +$2.53K | ﹤0.01% | 384 |
|
2023
Q4 | $13.3K | Buy |
230
+1
| +0.4% | +$58 | ﹤0.01% | 391 |
|
2023
Q3 | $12K | Buy |
229
+15
| +7% | +$786 | ﹤0.01% | 384 |
|
2023
Q2 | $12K | Buy |
+214
| New | +$12K | ﹤0.01% | 376 |
|
2018
Q4 | – | Sell |
-16,263
| Closed | -$626K | – | 703 |
|
2018
Q3 | $626K | Sell |
16,263
-16,900
| -51% | -$651K | 0.01% | 476 |
|
2018
Q2 | $1.08M | Buy |
33,163
+4,900
| +17% | +$160K | 0.02% | 430 |
|
2018
Q1 | $772K | Sell |
28,263
-1,000
| -3% | -$27.3K | 0.01% | 457 |
|
2017
Q4 | $726K | Buy |
29,263
+16,000
| +121% | +$397K | 0.01% | 455 |
|
2017
Q3 | $387K | Sell |
13,263
-11,100
| -46% | -$324K | 0.01% | 408 |
|
2017
Q2 | $676K | Hold |
24,363
| – | – | 0.02% | 370 |
|
2017
Q1 | $606K | Buy |
24,363
+400
| +2% | +$9.95K | 0.02% | 377 |
|
2016
Q4 | $518K | Buy |
23,963
+4,863
| +25% | +$105K | 0.01% | 398 |
|
2016
Q3 | $455K | Buy |
+19,100
| New | +$455K | 0.01% | 385 |
|